$NPCE
Neuropace, Inc. Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
$14.28
▲+0.92%+$0.130
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateNeuropace, Inc. Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Why is NPCE up today? It is at $14.28 (+0.92%), and our scanner flagged it 6 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NPCE spikes, and full due diligence on NPCE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NPCE 6 times in the last 30 days. Create a free account to track $NPCE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NPCE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NPCE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Insider trade (Form 4)Sep 4, 2026 · 15 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Becker Joel Officer | Sold (automatic/other) | -1K | sold 0.9% | 138K | $19K at $14.75 | Sep 3, 26 |
Morrell Martha Officer | Sold (automatic/other) | -358 | sold 0.7% | 52K | $5K at $14.13 | Aug 27, 26 |
Becker Joel Officer | Sold (automatic/other) | -1K | sold 0.8% | 139K | $16K at $14.13 | Aug 27, 26 |
Morrell Martha Officer | Sold (automatic/other) | -335 | sold 0.6% | 52K | $5K at $16.22 | Jun 24, 26 |
Kumar Rakhi Director | Acquired (grant/award) | +989 | added 4.5% | 23K | $15K at $15.63 | Jun 19, 26 |
Fischer Frank M Director | Acquired (grant/award) | +1K | added 0.2% | 600K | $23K at $15.63 | Jun 19, 26 |
Geiger Uri Director | Acquired (grant/award) | +789 | added 4.4% | 19K | $12K at $15.63 | Jun 19, 26 |
Andrade Lisa Director | Acquired (grant/award) | +3K | n/a | 3K | n/a | Jun 5, 26 |
Ryan Renee Director | Acquired (grant/award) | +3K | n/a | 3K | n/a | Jun 5, 26 |
Kumar Rakhi Director | Acquired (grant/award) | +3K | added 15% | 22K | n/a | Jun 5, 26 |
Geiger Uri Director | Acquired (grant/award) | +3K | added 19% | 18K | n/a | Jun 5, 26 |
Fischer Frank M Director | Acquired (grant/award) | +3K | added 0.5% | 598K | n/a | Jun 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in surgical & medical instruments & apparatus, closest in size first.
Here is the latest on NPCE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NPCE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
NPCE last traded at $14.28, up 0.92% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Neuropace, Inc. Common Stock (NPCE) is next expected to report earnings on Tuesday, November 3, 2026, about 44 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NPCE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NPCE 6 times in the last 30 days.
NPCE (Neuropace, Inc. Common Stock) trades on XNAS, with a market cap of about $490M in the Surgical & Medical Instruments & Apparatus sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NPCE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NPCE discussion
Sign in to ask a question or join the discussion.